ecrin-mdr-crcClinical2020IPD Sharing (as of March 2023): NoAdenocarcinomaNeoplasm MetastasisGastroesophageal Junction AdenocarcinomaEsophageal NeoplasmsNeoplasms, Second PrimaryMelanomaColorectal CancerGastric CancerColorectal NeoplasmsStomach NeoplasmsMetastatic CancerNeoplasmsAdenocarcinomaNeoplasm MetastasisGastroesophageal Junction AdenocarcinomaEsophageal NeoplasmsNeoplasms, Second PrimaryMelanomaColorectal CancerGastric CancerColorectal NeoplasmsStomach NeoplasmsMetastatic CancerNeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2325451United States1CRC-MSSGEJ AdenocarcinomaVE800NivolumabOpdivoBMSVancomycinVedantaECRIN MDRCompletedfalseStudy of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic CancerThis study evaluated the safety and efficacy of VE800 in combination with nivolumab in patients with selected types of advanced or metastatic cancer2020-01-152325451NCT04208958